The purpose of the study is to compare patients with cardiogenic shock who receive standard therapy plus therapeutic hypothermia (TH) to patients with cardiogenic shock who receive standard medical therapy alone in order to assess the safety of TH in patients with cardiogenic shock. This study will also help understand the physiologic effects of TH in patients with cardiogenic shock. This will be a pilot study to establish the initial safety of TH and to assess tolerability of TH in this patient population.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants With Episodes of Arrhythmia
Timeframe: up to 96 hours
Number of Participants With Bleeding
Timeframe: up to 96 hours
Number of Participants With Bloodstream Infection/Suspected Sepsis
Timeframe: up to 96 hours
Number of Participants With Hypokalemia
Timeframe: up to 96 hours